Research programme: vitamin D analogues and prohormones - OPKO Health

Drug Profile

Research programme: vitamin D analogues and prohormones - OPKO Health

Alternative Names: CTA 084; CTA 192

Latest Information Update: 08 Mar 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cytochroma
  • Class Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Hyperparathyroidism

Most Recent Events

  • 08 Mar 2013 No development reported - Preclinical for Hyperparathyroidism in Canada (IV)
  • 04 Mar 2013 Cytochroma has been acquired by OPKO Health
  • 18 Nov 2010 Preclinical pharmacodynamics data released by Cytochroma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top